GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
LDVCX
Price
$25.71
Change
-$0.27 (-1.04%)
Updated
Nov 18 closing price
Net Assets
101.47M
Interact to see
Advertisement

GFACX vs LDVCX

Header iconGFACX vs LDVCX Comparison
Open Charts GFACX vs LDVCXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
AXS FTSE Vntr Cptl RetTrckr C
Price$25.71
Change-$0.27 (-1.04%)
VolumeN/A
Net Assets101.47M
GFACX vs LDVCX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. LDVCX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and LDVCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. LDVCX (101M). GFACX (0.00) and LDVCX (0.00) have matching dividends . GFACX was incepted earlier than LDVCX: GFACX (25 years) vs LDVCX (10 years). LDVCX (2.72) is less costly to investors than GFACX (1.36). LDVCX is a more actively managed with annual turnover of: 29.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than LDVCX: GFACX (250) vs LDVCX (2500). LDVCX annual gain was more profitable for investors over the last year : 11.22 vs. GFACX (5.07). GFACX return over 5 years is better than : 24.08 vs. LDVCX (-9.75).
GFACXLDVCXGFACX / LDVCX
Total Expense Ratio1.362.5054%
Annual Report Gross Expense Ratio1.362.7250%
Fund Existence25 years10 years-
Gain YTD14.44513.599106%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets330B101M326,733%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.0711.2245%
Returns for 3 years54.86108.5151%
Returns for 5 years24.08-9.75-247%
Returns for 10 years69.66136.1151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining